#London #United Kingdom #Clinical Trials #Automation Tool #Research Grid

Revolutionizing Clinical Trial Feasibility with Research Grid

In an exciting advancement for the medical research community, Research Grid has unveiled a new Site Feasibility solution that promises to reshape the landscape of clinical trials. Traditionally, the feasibility process to select and activate trial sites has been a time-consuming ordeal, often extending up to six months due to the complexities involved. However, with Research Grid's innovative approach, this lengthy process has now been condensed to mere minutes.

Addressing a Critical Bottleneck

The traditional feasibility process has long been considered a significant bottleneck for trial sponsors and Contract Research Organizations (CROs). With up to 80% of trials missing their enrollment deadlines and about 30% of sites under-enrolling participants, the implications for both research quality and patient access are profound. Adding to this challenge, 85% of studies require costly extensions because of recruitment delays, while sites may spend over 4,500 hours annually managing feasibility processes.

Dr. Amber Hill, the founder and CEO of Research Grid, highlighted the critical nature of this development. "Site feasibility has long been a major cause of delay and inequity in clinical research. We're showing that with the right AI tech, trials can be safely admin-free. This means life-saving treatments can succeed in trials and reach patients faster than ever."

The Power of Automation

Research Grid's new Site Feasibility solution harnesses the potential of real-world data and connects it with a proprietary network that spans over 96,000 verified communities across 157 countries, covering more than 2,000 medical indications. The technology provides trial sponsors with instant, protocol-specific insights, dramatically reducing the delays typically seen in trial planning.

Key Features of the Solution:

• - Global Patient Access: Connect with verified communities specifically matched to trial needs, ensuring diverse and relevant recruitment landscapes.
• - Accelerated Planning: Replace cumbersome manual outreach processes with automated feasibility reports and risk-scored site surveys, allowing quicker decision-making.
• - Equity-Driven Design: Identify underrepresented regions and locations to enhance inclusive patient enrollment, improving trial demographic representation.
• - Improved Recruitment: Focus on sites that have real access to eligible patients rather than relying on historical performance metrics.
• - Unified Workflow: Streamline the planning, comparison, and tracking of feasibility activities across global teams, ensuring better collaboration.

Availability and Flexibility

The Site Feasibility solution is accessible now, available as either a self-service tool for sponsors who wish to conduct assessments independently or as a fully managed service for those seeking comprehensive support across multiple studies globally. This flexibility makes it easier for trial sponsors to optimize their trial processes, whether for a single study or an entire portfolio.

Research Grid’s launch of this tool is a significant step towards phasing out outdated manual systems and promoting intelligent automation in clinical trials. This advancement is poised to make clinical trials not only faster and more efficient but also more inclusive, ultimately moving the industry closer to achieving a more equitable healthcare landscape.

About Research Grid

Established in 2020 and headquartered in London, Research Grid aims to eliminate barriers imposed by legacy software and ineffective manual processes in clinical trials. With $8 million in venture funding, the company is committed to leveraging advanced technology to ensure faster, more successful trials.

By addressing inefficiencies in the clinical research field, Research Grid stands to benefit not only researchers and sponsors but also the patients who rely on timely access to innovative medical treatments. As we look towards the future of clinical trials, this company is at the forefront of a necessary evolution in how trials are conducted and managed across the globe.